Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Moodys
Dow
Cipla
Harvard Business School
Teva
McKinsey
Novartis
Cerilliant

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,273,341

« Back to Dashboard

Which drugs does patent 8,273,341 protect, and when does it expire?

Patent 8,273,341 protects HARVONI and is included in one NDA.

This patent has eighty-six patent family members in thirty-six countries.
Summary for Patent: 8,273,341
Title:Antiviral compounds
Abstract: The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Inventor(s): Guo; Hongyan (Foster City, CA), Kato; Darryl (Foster City, CA), Kirschberg; Thorsten A. (Foster City, CA), Liu; Hongtao (Foster City, CA), Link; John O. (Foster City, CA), Mitchell; Michael L. (Foster City, CA), Parrish; Jay P. (Foster City, CA), Graupe; Michael (Foster City, CA), Sun; Jianyu (Foster City, CA), Taylor; James (Foster City, CA), Bacon; Elizabeth M. (Foster City, CA), Canales; Eda (Foster City, CA), Cho; Aesop (Foster City, CA), Kim; Choung U. (Foster City, CA), Cottell; Jeromy J. (Foster City, CA), Desai; Manoj C. (Foster City, CA), Halcomb; Randall L. (Foster City, CA), Krygowski; Evan S. (Foster City, CA), Lazerwith; Scott E. (Foster City, CA), Liu; Qi (Foster City, CA), Mackman; Richard (Foster City, CA), Pyun; Hyung-Jun (Foster Cit, CA), Saugier; Joseph H. (Foster City, CA), Trenkle; James D. (Foster City, CA), Tse; Winston C. (Foster City, CA), Vivian; Randall W. (Foster City, CA), Schroeder; Scott D. (Foster City, CA), Watkins; William J. (Foster City, CA), Xu; Lianhong (Foster City, CA)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Application Number:13/291,977
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 8,273,341

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Gilead Sciences Inc HARVONI ledipasvir; sofosbuvir TABLET;ORAL 205834-001 Oct 10, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe FOR THE TREATMENT OF HEPATITIS C ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,273,341

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,088,368 Antiviral compounds ➤ Subscribe
8,841,278 Antiviral compounds ➤ Subscribe
9,511,056 Antiviral compounds ➤ Subscribe
8,575,118 Antiviral compounds ➤ Subscribe
8,669,234 Antiviral compounds ➤ Subscribe
8,822,430 Antiviral compounds ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,273,341

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
South Korea 20170041924 ➤ Subscribe
South Korea 20140122705 ➤ Subscribe
South Korea 101727876 ➤ Subscribe
South Korea 20160084478 ➤ Subscribe
South Korea 20140014393 ➤ Subscribe
South Korea 101546119 ➤ Subscribe
South Korea 20140122706 ➤ Subscribe
South Korea 101503752 ➤ Subscribe
Japan 2017145254 ➤ Subscribe
Japan 2015157842 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Dow
QuintilesIMS
Johnson and Johnson
Fish and Richardson
UBS
Julphar
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot